Literature DB >> 11937005

Genetic analysis of multiple sclerosis.

Alastair Compston1, Stephen Sawcer.   

Abstract

The increased recurrence risk within families indicates a role for genetic factors in the etiology of multiple sclerosis. Genes may influence susceptibility to the development of multiple sclerosis and the subsequent course of the disease. To date, associations have only been demonstrated consistently with class II major histocompatibility complex (MHC) alleles. The relatively low yield from additional candidate gene studies is only modestly advanced by several whole-genome linkage analyses, and by the first in a series of planned whole-genome linkage disequilibrium screens for allelic associations. The aims of linkage and association are to narrow the search for chromosomal regions encoding genes for multiple sclerosis and, with information from the human gene project, suggest new positional candidates. In time, it is expected that these genes will include some that confer susceptibility to the general process of autoimmunity, others that are specific for multiple sclerosis in all populations, some that act only in defined ethic groups, and those that determine particular phenotypes or shape the clinical course. These genetic analyses are predicated on the assumption that multiple sclerosis is one disease; a major part of future studies will be to resolve the question of disease heterogeneity in multiple sclerosis. When eventually in place, the potential of this genetic knowledge for improved understanding of the pathogenesis of multiple sclerosis and designing novel treatments is considerable.

Entities:  

Mesh:

Year:  2002        PMID: 11937005     DOI: 10.1007/s11910-002-0085-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  72 in total

1.  A full genome search in multiple sclerosis.

Authors:  G C Ebers; K Kukay; D E Bulman; A D Sadovnick; G Rice; C Anderson; H Armstrong; K Cousin; R B Bell; W Hader; D W Paty; S Hashimoto; J Oger; P Duquette; S Warren; T Gray; P O'Connor; A Nath; A Auty; L Metz; G Francis; J E Paulseth; T J Murray; W Pryse-Phillips; R Nelson; M Freedman; D Brunet; J P Bouchard; D Hinds; N Risch
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

Authors:  A D Sadovnick; G C Ebers; D A Dyment; N J Risch
Journal:  Lancet       Date:  1996-06-22       Impact factor: 79.321

3.  Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis.

Authors:  N P Robertson; J I O'Riordan; J Chataway; D P Kingsley; D H Miller; D Clayton; D A Compston
Journal:  Lancet       Date:  1997-05-31       Impact factor: 79.321

4.  Role of myelin basic protein and proteolipid protein genes in multiple sclerosis: single strand conformation polymorphism analysis of the human sequences.

Authors:  S E Price; G Sharpe; A Boots; A Poutsma; C Mason; J James; L Hinks; R J Thompson
Journal:  Neuropathol Appl Neurobiol       Date:  1997-12       Impact factor: 8.090

5.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11.

Authors:  P Reed; F Cucca; S Jenkins; M Merriman; A Wilson; P McKinney; E Bosi; G Joner; K S Rønningen; K Rønningen; E Thorsby; D Undlien; T Merriman; A Barnett; S Bain; J Todd
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

7.  Risks of multiple sclerosis in relatives of patients in Flanders, Belgium.

Authors:  H Carton; R Vlietinck; J Debruyne; J De Keyser; M B D'Hooghe; R Loos; R Medaer; L Truyen; I M Yee; A D Sadovnick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

8.  SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.

Authors:  E R Martin; E H Lai; J R Gilbert; A R Rogala; A J Afshari; J Riley; K L Finch; J F Stevens; K J Livak; B D Slotterbeck; S H Slifer; L L Warren; P M Conneally; D E Schmechel; I Purvis; M A Pericak-Vance; A D Roses; J M Vance
Journal:  Am J Hum Genet       Date:  2000-06-21       Impact factor: 11.025

9.  Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study.

Authors:  B G Weinshenker; P Santrach; A S Bissonet; S K McDonnell; D Schaid; S B Moore; M Rodriguez
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  The extent of linkage disequilibrium in four populations with distinct demographic histories.

Authors:  A M Dunning; F Durocher; C S Healey; M D Teare; S E McBride; F Carlomagno; C F Xu; E Dawson; S Rhodes; S Ueda; E Lai; R N Luben; E J Van Rensburg; A Mannermaa; V Kataja; G Rennart; I Dunham; I Purvis; D Easton; B A Ponder
Journal:  Am J Hum Genet       Date:  2000-11-14       Impact factor: 11.043

View more
  7 in total

Review 1.  New approaches to investigating heterogeneity in complex traits.

Authors:  R Bomprezzi; P E Kovanen; R Martin
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

2.  Mitochondrial D-loop variation in Persian multiple sclerosis patients: K and A haplogroups as a risk factor!!

Authors:  Hassan Hassani-Kumleh; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Gholam Hossein Riazi; Mohammad Hossein Sanati; Kurosh Gharagozli; Mojdeh Ghabaee
Journal:  Cell Mol Neurobiol       Date:  2006-05-06       Impact factor: 5.046

3.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 4.  The noncalciotropic actions of vitamin D: recent clinical developments.

Authors:  Naim M Maalouf
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

5.  Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.

Authors:  Yen Chih Lin; Paige Winokur; Andrew Blake; Tianxia Wu; Elena Romm; Bibiana Bielekova
Journal:  Ann Clin Transl Neurol       Date:  2015-04-07       Impact factor: 4.511

Review 6.  Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management.

Authors:  Sudhir Kumar; Anshu Rohatgi; Harshal Chaudhari; Priti Thakor
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

7.  The impact of the human genome project on complex disease.

Authors:  Jessica N Cooke Bailey; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genes (Basel)       Date:  2014-07-16       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.